US Patent Issued to MERCK PATENT, RYVU THERAPEUTICS on July 7 for "Substituted tetrazoles as ACSS2 inhibitors" (German Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,046, issued on July 7, was assigned to MERCK PATENT GMBH (Darmstadt, Germany) and RYVU THERAPEUTICS S.A. (Krawkow, Poland).

"Substituted tetrazoles as ACSS2 inhibitors" was invented by Thomas Fuchss (Darmstadt, Germany), Lisa Koetzner (Darmstadt, Germany), Christina Schindler (Darmstadt, Germany) and Daniel Kuhn (Darmstadt, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "Substituted tetrazoles of formula I-a, I-b, or I-c:or a pharmaceutically acceptable salt, deuteroisotope, stereoisomer or tautomer thereof; useful as ACSS2 inhibitors are provided."

The patent was filed on March 16, 2021, under Application No. 17/906,600.

*For further inform...